InvestorsHub Logo
Followers 58
Posts 10359
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Tuesday, 06/08/2021 10:36:45 AM

Tuesday, June 08, 2021 10:36:45 AM

Post# of 471350

Recognizing that clinical trials of the drug had provided incomplete evidence to demonstrate effectiveness, the F.D.A. granted approval for the drug to be used but required Biogen to conduct a new clinical trial.



https://www.msn.com/en-us/health/medical/f-d-a-approves-alzheimer-s-drug-despite-fierce-debate-over-whether-it-works/ar-AAKN9W6?ocid=msedgntp

What kind of twisted logic admits the trials were inconclusive but allows the drug to be licensed for use? Totally moronic.

These are the people we are deferring to for the care of our families? Complete farce obviously controlled by big money. I hope they are all locked up.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News